Is Double-Blinding Achievable in Placebo-Controlled Trials with the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide?Signe Foghsgaard,Louise Vedtofte, Emilie Bahne,Camilla Andreasen, Liselotte K. Christiansen,Tine D. Clausen,Jens A. Svare,Elisabeth R. Mathiesen,Peter Damm,Lise L. Gluud,Filip K. Knop,Tina VilsbollDIABETES(2017)引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要